Skip to main content
Premium Trial:

Request an Annual Quote

Celmatix Wins $4.5M From New York State to Expand NYC Headquarters

NEW YORK (GenomeWeb) – Women's health company Celmatix has received $4.5 million from the Empire State Development's New York City Regional Economic Development Council (REDC) to expand its headquarters in Manhattan, the company said today.

The award is one of 121 for projects in New York City this year, totaling $64.8 million. Overall, the REDC program awarded more than $755 million in funding to different regions of New York state in 2017.

Celmatix, founded in 2009, currently offers two products: Polaris, a web-based data analytics platform for patient management and counseling, and Fertilome, a genetic test to assess the risk for certain reproductive conditions.

Last month, the company received approval from the New York State Department of Health for the Fertilome test.

The Scan

Less Than Half

An effort to reproduce key findings from high-profile preclinical cancer studies finds less than half could be replicated, according to the Scientist.

Still Some SARS-CoV-2 Sequencing Holes

The Wall Street Journal reports that viral genomic surveillance has improved in the US, though says there are still gaps.

Avoiding Passing Them On

People with known disease-linked genetic variants are turning to in vitro fertilization so as to not pass those variants to their children, the Washington Post says.

PNAS Papers on Long Cell-Free DNA in Maternal Plasma, Genetic Propensity for Voting

In PNAS this week: long, cell-free DNA of maternal and fetal origins identified in maternal plasma, and more.